Intron Biotechnology products

Related News

No related news articles were found.

intron biotechnology inc (048530) Related Businessweek News

intron biotechnology inc (048530) Details

iNtRON Biotechnology, Inc., a bio new drug company, develops, manufactures, and commercializes bio-medicines targeting infectious diseases. The company offers super bacteria drugs, such as Sal 200 and NPA 200; cancer treating drug delivery media; heme-iron supplements, antibiotic alternative products for animals; and various lab reagents and kits, as well as nucleic acid tests for new flu, VRE super bacteria, food poison, and Al. iNtRON Biotechnology, Inc. was founded in 1999 and is headquartered in Seongnam, South Korea.

intron biotechnology inc (048530) Key Developments

iNtRON Biotechnology, Inc., Annual General Meeting, Mar 27, 2015

Feb 12 15

iNtRON Biotechnology, Inc., Annual General Meeting, Mar 27, 2015., at 10:00 Korea Standard Time. Location: 137 Jungwon-gu, Seongnam, Gyeonggi sagimakgol to sangdaewondong, Central indeoseupiah 503 of the 5th. Agenda: To consider the approval of financial statements.

iNtRON Biotechnology, Inc. Proposes Amendments to Articles of Incorporation

Nov 7 14

iNtRON Biotechnology, Inc. proposed amendments to Articles of Incorporation to be approved at the EGM to be held on December 24, 2014.

iNtRON Biotechnology, Inc., Special/Extraordinary Shareholders Meeting, Dec 24, 2014

iNtRON Biotechnology, Inc., Special/Extraordinary Shareholders Meeting, Dec 24, 2014., at 10:00 Korea Standard Time. Location: Headquarters conference room. Agenda: To approve some changes to the Articles of Incorporation Articles; and to approve the Audit Senior Articles.